Celltrion today announced the U.S. launch of STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), following ...

Two-thirds of patients with moderate or severe plaque psoriasis had complete or nearly complete clearance at 4 months with an ...

Until about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an ...

Focus on everything you need to get done with a to-do list app filled with smart features. Whether you're using the desktop app at home or the mobile app on the go, access your task list and stay ...

Wildfire smoke exposure acutely increased IL-13 expression in NK cells and was negatively associated with COVID-19 vaccine immunity.

Topline results from Phase 3 ICONIC-ADVANCE 1&2�studies show icotrokinra achieved co-primary endpoints and showed superiority to deucravacitinib in moderate-to-severe plaque PsO ...

Shares of Kestra Medical, a wearable cardiac device maker, soared in the company’s public debut this week. Meanwhile, Discord is said to be in ...

Standout combination of complete skin clearance and favorable safety profile in a once daily pill could shift treatment paradigm Nearly half of patients with moderate-to-severe ...

aDepartment of Sleep Medicine, Shantou University Mental Health Center, Shantou University Medical College, Shantou 515041, China bSleep Medicine Center, Shantou University Medical College, Shantou, ...

Two more people have been potentially cured of HIV after receiving stem cell transplants to treat blood cancer or bone marrow disease, physicians reported Monday.